This column is a collaboration withDoubleBlind, a print magazine and media company at the forefront of the psychedelic movement. This fall, the federal government granted researchers funding to study the therapeutic potential of a classic psychedelic for the first time in 50 years. The National Institutes of Health granted Johns …
Read More »